Articles About NASDAQ:GALE
February 19, 2014
News releases and data from the NeuVax trials will move the stock in the coming months and years.
February 17, 2014
Galena is developing innovative targeted oncology therapies that address major unmet needs in the industry to advance cancer treatments.
February 15, 2014
For the long-term speculative investor, Galena actually presents a high risk, but a very high reward play should the company meet its goals.
January 17, 2014
Galena Pharmaceuticals stock has jumped 50 percent year-to-date. Jim Cramer advises watching the stock in future.
January 15, 2014
With a slew of catalysts coming later this year and a stock market that doesn’t appear to be slowing, investors may be in store for one heck of a run.